Skip to main content

HPQ Announces Second and Final Closing of Private Placement

MONTREAL, July 11, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to announce it has closed yesterday the Non-Brokered Private placement financing first announced on May 29, 2025. In addition to the 3,158,000 units announced on June 19, 2025, the company announces the closing of additional 1,886,331 units at a price of $ 0.18 per unit for a gross proceed of $339,539.58, bringing the total amount raised at $907,979.58 and the total number of units issued at 5,044,331. Each Unit is comprised of one (1) common share and one (1) common share purchase warrant of the Company. Each Warrant will entitle the holder thereof to purchase one common share of the capital stock of...

Continue reading

Toll Brothers Announces New Luxury 55+ Townhome Community Coming Soon to Danbury, Connecticut

DANBURY, Conn., July 11, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest 55+ community, Rivington by Toll Brothers – The Meadows Collection, is coming soon to prestigious Fairfield County in Danbury, Connecticut. This exclusive Toll Brothers neighborhood will offer the final collection of new construction townhomes in the award-winning Rivington by Toll Brothers community. Sales are anticipated to begin in late summer 2025. Rivington by Toll Brothers – The Meadows Collection will feature townhomes up to 2,594 square feet with 3 to 4 bedrooms including first-floor primary bedroom suites, open-concept floor plans, optional finished basements, gorgeous outdoor living options, and more. Townhomes are anticipated to be priced from the upper...

Continue reading

Siili Solutions Plc: Share Repurchase 11.7.2025

Siili Solutions Plc       Announcement  11.7.2025          Siili Solutions Plc: Share Repurchase 11.7.2025       In the Helsinki Stock Exchange         Trade date           11.7.2025  Bourse trade         Buy  Share                  SIILI  Amount             800 SharesAverage price/ share    6,4600 EURTotal cost            5 168,00 EUR          Siili Solutions Plc now holds a total of 28 228 sharesincluding the shares repurchased on 11.7.2025       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.     On behalf of Siili Solutions Plc         Nordea Bank Oyj         Sami Huttunen Ilari Isomäki       Further...

Continue reading

Thierry Mirville appointed Deputy CFO of VINCI                                                                        

thierry-mirville-appointed-deputy-cfo-of-vincivinciNanterre, 11 July 2025 Thierry Mirville appointed Deputy CFO of VINCI                                                                         Thierry Mirville will join VINCI’s Finance Department on October 1st as Deputy Chief Financial Officer. He will report to Christian Labeyrie, Executive Vice-President and Chief Financial Officer of VINCI. This appointment comes ahead of Christian Labeyrie’s retirement in 2026. A graduate of ESSEC Business School and of the Institut d’Etudes Politiques de Paris, Thierry Mirville began his professional career in 1991 at GTIE, a subsidiary of Compagnie Générale de Eaux. He was appointed Chief Financial Officer of VINCI Energies Deutschland in 2003 and became Chief Financial Officer of VINCI Energies in 2006. In 2018, he joined...

Continue reading

Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly

Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva’s single-dose chikungunya vaccine IXCHIQ® by EMA’s safety committee (PRAC). The committee initiated its review at the beginning of May following the occurrence of serious side effects mainly in elderly people with several underlying medical conditions. In a press release published today on its website1, EMA underlined that the vaccine is already contraindicated for people with a weakened immune system and concluded that, for people of all ages, IXCHIQ® should be given when there is a significant risk of chikungunya infection and after a...

Continue reading

Toll Brothers Announces Final Opportunity to Own a New Luxury Townhome at its Rollingdale Community in Durham, North Carolina

DURHAM, N.C., July 11, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to buy a new home at Rollingdale by Toll Brothers, a premier community of new construction townhomes in Durham, North Carolina. Only nine homes remain available for sale in this exclusive community, including move-in ready homes with designer appointed finishes. The Toll Brothers Sales Center is open daily at 2117 Opulent Oaks Lane in Durham. Rollingdale by Toll Brothers features exceptionally designed floor plans with distinct architecture and modern appointments, all situated within a highly desirable setting. The community offers two modern home designs with 4 bedrooms, 3.5 bathrooms, and 2-car garages. Residents also enjoy low-maintenance living with lawn care provided....

Continue reading

BROAD ARROW ANNOUNCES INAUGURAL LAS VEGAS AUCTION IN PARTNERSHIP WITH CONCOURS AT WYNN LAS VEGAS

APPROXIMATELY 70 EXCEPTIONAL COLLECTOR CARS WILL BE AUCTIONED ON OCTOBER 31 AT WYNN LAS VEGASAn iconic scene from the 2023 Concours at Wynn Las VegasCredit – Courtesy of Concours at Wynn Las VegasBest of Show winners at the 2024 Concours at Wynn Las VegasCredit – Courtesy of Concours at Wynn Las VegasGrosse Pointe, Michigan, July 11, 2025 (GLOBE NEWSWIRE) — GROSSE POINTE, Michigan (July 11, 2025) – Broad Arrow Auctions, a Hagerty (NYSE: HGTY) company, adds to its growing fall auction calendar with the announcement of The Las Vegas Auction—held in partnership with Concours at Wynn Las Vegas. Occurring on Friday, October 31, 2025, Broad Arrow’s Las Vegas Auction will feature approximately 70 highly desirable collector cars and is expected to be a cornerstone event of the weekend. Returning for...

Continue reading

NuCana Announces Plan to Implement ADS Ratio Change

EDINBURGH, United Kingdom, July 11, 2025 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing twenty-five (25) ordinary shares, to one (1) ADS representing five thousand (5,000) ordinary shares (the “ADS Ratio”). The change in the ADS Ratio is expected to become effective on or about August 8, 2025 (the “Effective Date”). For the Company’s ADS holders, the change in the ADS Ratio has the same effect as a one-for-two hundred reverse ADS split and will have no impact on an ADS holder’s proportional equity interest in the Company. The change in the ADS Ratio is intended to further support the liquidity in the Company’s ADSs and to enable the Company to...

Continue reading

Gauzy Provides Additional Details on the Significant Insider Purchases of 560,000 Shares, Including 210,000 Shares by CEO and Co-Founder

CEO and Co-Founder purchases 210,000 shares and second largest long-term investor purchases 350,000 shares NEW YORK and TEL AVIV, Israel, July 11, 2025 (GLOBE NEWSWIRE) — Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, provided more details regarding the announcement this morning of significant insider purchases totaling 560,000 Gauzy ordinary shares from an existing investor. The transaction included 210,000 shares purchased by the CEO and Co-Founder, Eyal Peso, alongside an additional 350,000 shares purchased by Gauzy’s second largest, long-time investor and director nominee, Alejandro Weinstein. The private transaction was negotiated and signed in the first half of June 2025. Mr. Peso’s investment was financed entirely through a personal loan, further signaling...

Continue reading

Rakovina Therapeutics Congratulates Partner – Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award

Award Recognition underscores the importance of AI-driven drug discovery VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) —  Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through AI-powered drug discovery proudly congratulates partner, Variational AI, on being honored as the 2025 Emerging Company of the Year – Biotech by Life Sciences BC. This prestigious award recognizes a British Columbia-based biotechnology company demonstrating exceptional progress and achievement of key strategic milestones, attributes that reflect Variational AI’s impressive momentum and innovation in the field. Since entering into a partnership with Rakovina Therapeutics in September 2024, Variational AI has applied its Enki™ generative...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.